| 131I-MIBG |
Radiation
|
|
See Remarks
|
| 5-Aza-2'Deoxy-cytidine |
Chemotherapy
|
CML
|
Yes
|
| 5-FP |
Chemotherapy
|
Breast,
gastric,
head & neck,
liver cancer
|
Yes
|
| ABT 888 |
Chemotherapy
|
Ovary
|
Yes
|
| ADXS-HPV |
Biologic therapy (BRM, immunotherapy)
|
Cervix
|
Yes
|
| AMG 531 |
Ancillary Agent
|
|
No
|
| ATRA-IV |
Differentiation inducing agent
|
Lymphoma,
Acute promyelocytic leukemia
|
Yes
|
| Abecma |
Biologic therapy (BRM, immunotherapy)
|
|
Yes
|
| Abemaciclib |
Chemotherapy
|
Breast
|
Yes
|
| Abiraterone acetate |
Hormones and hormonal mechanisms
|
Prostate
|
Yes
|
| Abraxane |
Chemotherapy
|
Metastatic breast cancer,
NSCLC,
Non small cell lung cancer,
cervix,
melanoma,
pancreas
|
Yes
|
| Acalabrutinib |
Chemotherapy
|
|
Yes
|
| Accutane |
Differentiation inducing agent
|
Prostate cancer
|
No
|
| Acetaminophen |
Ancillary Agent
|
|
No
|
| Acetazolamide |
Ancillary Agent
|
|
No
|
| Acetylcysteine |
Ancillary Agent
|
AIDS,
Opportunistic infection
|
No
|
| Acitretin |
Differentiation inducing agent
|
|
No
|
| Acyclovir |
Ancillary Agent
|
|
No
|
| Acyclovir Sodium |
AIDS drug
|
|
No
|
| Ad5CMV-p53 (adenovirus p53) |
Biologic therapy (BRM, immunotherapy)
|
Glioma,
Head & neck,
lung cancer
|
No
|
| Ado-trastuzumab emtansine |
Biologic therapy (BRM, immunotherapy)
|
Metastatic HER-2 breast cancer
|
Yes
|
| Adrenocorticotropic hormone |
Hormones and hormonal mechanisms
|
|
See Remarks
|
| Adstiladrin |
Biologic therapy (BRM, immunotherapy)
|
bladder
|
Yes
|
| Afinitor |
Chemotherapy
|
breast,
Lung,
other cancer
|
Yes
|
| Akeega |
Chemotherapy
|
Prostate
|
See Remarks
|
Home
An official website of the United States government
